カテゴリ： 世界, 医療/バイオ, Market Monitor Global

CGRPアンタゴニストのグローバル市場展望 2023年-2029年：モノクローナル抗体、CGRP受容体阻害剤

■ 英語タイトル：CGRP Antagonists Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14275）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14275
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[CGRPアンタゴニストのグローバル市場展望 2023年-2029年：モノクローナル抗体、CGRP受容体阻害剤]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のCGRPアンタゴニスト市場規模と予測を収録しています。・世界のCGRPアンタゴニスト市場：売上、2018年-2023年、2024年-2029年
・世界のCGRPアンタゴニスト市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のCGRPアンタゴニスト市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「モノクローナル抗体」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

CGRPアンタゴニストのグローバル主要企業は、PFIZER INC(Biohaven)、 ABBVIE INC、 Amgen、 Teva、 Eli Lilly and Company、 Lundbeck、 Novartisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、CGRPアンタゴニストのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のCGRPアンタゴニスト市場：タイプ別、2018年-2023年、2024年-2029年
世界のCGRPアンタゴニスト市場：タイプ別市場シェア、2022年
・モノクローナル抗体、CGRP受容体阻害剤

世界のCGRPアンタゴニスト市場：用途別、2018年-2023年、2024年-2029年
世界のCGRPアンタゴニスト市場：用途別市場シェア、2022年
・病院、診療所、その他

世界のCGRPアンタゴニスト市場：地域・国別、2018年-2023年、2024年-2029年
世界のCGRPアンタゴニスト市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるCGRPアンタゴニストのグローバル売上、2018年-2023年
・主要企業におけるCGRPアンタゴニストのグローバル売上シェア、2022年
・主要企業におけるCGRPアンタゴニストのグローバル販売量、2018年-2023年
・主要企業におけるCGRPアンタゴニストのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
PFIZER INC(Biohaven)、 ABBVIE INC、 Amgen、 Teva、 Eli Lilly and Company、 Lundbeck、 Novartis

*************************************************************

・調査・分析レポートの概要
CGRPアンタゴニスト市場の定義
市場セグメント
世界のCGRPアンタゴニスト市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のCGRPアンタゴニスト市場規模
世界のCGRPアンタゴニスト市場規模：2022年 VS 2029年
世界のCGRPアンタゴニスト市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのCGRPアンタゴニストの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のCGRPアンタゴニスト製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：モノクローナル抗体、CGRP受容体阻害剤
CGRPアンタゴニストのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
CGRPアンタゴニストの用途別グローバル売上・予測

・地域別市場分析
地域別CGRPアンタゴニスト市場規模 2022年と2029年
地域別CGRPアンタゴニスト売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
PFIZER INC(Biohaven)、 ABBVIE INC、 Amgen、 Teva、 Eli Lilly and Company、 Lundbeck、 Novartis
...

This research report provides a comprehensive analysis of the CGRP Antagonists market, focusing on the current trends, market dynamics, and future prospects. The report explores the global CGRP Antagonists market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of CGRP Antagonists, challenges faced by the industry, and potential opportunities for market players.
The global CGRP Antagonists market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The CGRP Antagonists market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in CGRP Antagonists market. Additionally, the growing consumer demand present avenues for market expansion.
The global CGRP Antagonists market was valued at US$ 2690.9 million in 2022 and is projected to reach US$ 10260 million by 2029, at a CAGR of 21.1% during the forecast period.
The CGRP (calprotectin gene-related peptide) antagonist market is a rapidly growing field focused on developing drugs to treat migraine and other neuropathic pain symptoms. These drugs reduce or prevent migraine attacks by inhibiting the effects of CGRP, providing patients with more effective pain management options. Several CGRP antagonists are already approved and in use on the market, and more new drugs are in development. Growth in this market is driven by expanding patient demand and scientific research, providing hope and an opportunity to improve the quality of life for migraine sufferers.
Key Features:
The research report on the CGRP Antagonists market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the CGRP Antagonists market.
Market Overview: The report provides a comprehensive overview of the CGRP Antagonists market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monoclonal Antibodies, CGRP Receptor Inhibitor), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the CGRP Antagonists market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the CGRP Antagonists market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the CGRP Antagonists market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the CGRP Antagonists market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the CGRP Antagonists market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the CGRP Antagonists market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for CGRP Antagonists, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the CGRP Antagonists market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
CGRP Antagonists market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Monoclonal Antibodies
CGRP Receptor Inhibitor
Market segment by Application
Hospital
Clinic
Other
Global CGRP Antagonists Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
PFIZER INC(Biohaven)
ABBVIE INC
Amgen
Teva
Eli Lilly and Company
Lundbeck
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of CGRP Antagonists, market overview.
Chapter 2: Global CGRP Antagonists market size in revenue and volume.
Chapter 3: Detailed analysis of CGRP Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CGRP Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global CGRP Antagonists capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 CGRP Antagonists Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CGRP Antagonists Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CGRP Antagonists Overall Market Size
2.1 Global CGRP Antagonists Market Size: 2022 VS 2029
2.2 Global CGRP Antagonists Revenue, Prospects & Forecasts: 2018-2029
2.3 Global CGRP Antagonists Sales: 2018-2029
3 Company Landscape
3.1 Top CGRP Antagonists Players in Global Market
3.2 Top Global CGRP Antagonists Companies Ranked by Revenue
3.3 Global CGRP Antagonists Revenue by Companies
3.4 Global CGRP Antagonists Sales by Companies
3.5 Global CGRP Antagonists Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 CGRP Antagonists Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers CGRP Antagonists Product Type
3.8 Tier 1, Tier 2 and Tier 3 CGRP Antagonists Players in Global Market
3.8.1 List of Global Tier 1 CGRP Antagonists Companies
3.8.2 List of Global Tier 2 and Tier 3 CGRP Antagonists Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global CGRP Antagonists Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 CGRP Receptor Inhibitor
4.2 By Type – Global CGRP Antagonists Revenue & Forecasts
4.2.1 By Type – Global CGRP Antagonists Revenue, 2018-2023
4.2.2 By Type – Global CGRP Antagonists Revenue, 2024-2029
4.2.3 By Type – Global CGRP Antagonists Revenue Market Share, 2018-2029
4.3 By Type – Global CGRP Antagonists Sales & Forecasts
4.3.1 By Type – Global CGRP Antagonists Sales, 2018-2023
4.3.2 By Type – Global CGRP Antagonists Sales, 2024-2029
4.3.3 By Type – Global CGRP Antagonists Sales Market Share, 2018-2029
4.4 By Type – Global CGRP Antagonists Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global CGRP Antagonists Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global CGRP Antagonists Revenue & Forecasts
5.2.1 By Application – Global CGRP Antagonists Revenue, 2018-2023
5.2.2 By Application – Global CGRP Antagonists Revenue, 2024-2029
5.2.3 By Application – Global CGRP Antagonists Revenue Market Share, 2018-2029
5.3 By Application – Global CGRP Antagonists Sales & Forecasts
5.3.1 By Application – Global CGRP Antagonists Sales, 2018-2023
5.3.2 By Application – Global CGRP Antagonists Sales, 2024-2029
5.3.3 By Application – Global CGRP Antagonists Sales Market Share, 2018-2029
5.4 By Application – Global CGRP Antagonists Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global CGRP Antagonists Market Size, 2022 & 2029
6.2 By Region – Global CGRP Antagonists Revenue & Forecasts
6.2.1 By Region – Global CGRP Antagonists Revenue, 2018-2023
6.2.2 By Region – Global CGRP Antagonists Revenue, 2024-2029
6.2.3 By Region – Global CGRP Antagonists Revenue Market Share, 2018-2029
6.3 By Region – Global CGRP Antagonists Sales & Forecasts
6.3.1 By Region – Global CGRP Antagonists Sales, 2018-2023
6.3.2 By Region – Global CGRP Antagonists Sales, 2024-2029
6.3.3 By Region – Global CGRP Antagonists Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America CGRP Antagonists Revenue, 2018-2029
6.4.2 By Country – North America CGRP Antagonists Sales, 2018-2029
6.4.3 US CGRP Antagonists Market Size, 2018-2029
6.4.4 Canada CGRP Antagonists Market Size, 2018-2029
6.4.5 Mexico CGRP Antagonists Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe CGRP Antagonists Revenue, 2018-2029
6.5.2 By Country – Europe CGRP Antagonists Sales, 2018-2029
6.5.3 Germany CGRP Antagonists Market Size, 2018-2029
6.5.4 France CGRP Antagonists Market Size, 2018-2029
6.5.5 U.K. CGRP Antagonists Market Size, 2018-2029
6.5.6 Italy CGRP Antagonists Market Size, 2018-2029
6.5.7 Russia CGRP Antagonists Market Size, 2018-2029
6.5.8 Nordic Countries CGRP Antagonists Market Size, 2018-2029
6.5.9 Benelux CGRP Antagonists Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia CGRP Antagonists Revenue, 2018-2029
6.6.2 By Region – Asia CGRP Antagonists Sales, 2018-2029
6.6.3 China CGRP Antagonists Market Size, 2018-2029
6.6.4 Japan CGRP Antagonists Market Size, 2018-2029
6.6.5 South Korea CGRP Antagonists Market Size, 2018-2029
6.6.6 Southeast Asia CGRP Antagonists Market Size, 2018-2029
6.6.7 India CGRP Antagonists Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America CGRP Antagonists Revenue, 2018-2029
6.7.2 By Country – South America CGRP Antagonists Sales, 2018-2029
6.7.3 Brazil CGRP Antagonists Market Size, 2018-2029
6.7.4 Argentina CGRP Antagonists Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa CGRP Antagonists Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa CGRP Antagonists Sales, 2018-2029
6.8.3 Turkey CGRP Antagonists Market Size, 2018-2029
6.8.4 Israel CGRP Antagonists Market Size, 2018-2029
6.8.5 Saudi Arabia CGRP Antagonists Market Size, 2018-2029
6.8.6 UAE CGRP Antagonists Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 PFIZER INC(Biohaven)
7.1.1 PFIZER INC(Biohaven) Company Summary
7.1.2 PFIZER INC(Biohaven) Business Overview
7.1.3 PFIZER INC(Biohaven) CGRP Antagonists Major Product Offerings
7.1.4 PFIZER INC(Biohaven) CGRP Antagonists Sales and Revenue in Global (2018-2023)
7.1.5 PFIZER INC(Biohaven) Key News & Latest Developments
7.2 ABBVIE INC
7.2.1 ABBVIE INC Company Summary
7.2.2 ABBVIE INC Business Overview
7.2.3 ABBVIE INC CGRP Antagonists Major Product Offerings
7.2.4 ABBVIE INC CGRP Antagonists Sales and Revenue in Global (2018-2023)
7.2.5 ABBVIE INC Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen CGRP Antagonists Major Product Offerings
7.3.4 Amgen CGRP Antagonists Sales and Revenue in Global (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 Teva
7.4.1 Teva Company Summary
7.4.2 Teva Business Overview
7.4.3 Teva CGRP Antagonists Major Product Offerings
7.4.4 Teva CGRP Antagonists Sales and Revenue in Global (2018-2023)
7.4.5 Teva Key News & Latest Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Company Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company CGRP Antagonists Major Product Offerings
7.5.4 Eli Lilly and Company CGRP Antagonists Sales and Revenue in Global (2018-2023)
7.5.5 Eli Lilly and Company Key News & Latest Developments
7.6 Lundbeck
7.6.1 Lundbeck Company Summary
7.6.2 Lundbeck Business Overview
7.6.3 Lundbeck CGRP Antagonists Major Product Offerings
7.6.4 Lundbeck CGRP Antagonists Sales and Revenue in Global (2018-2023)
7.6.5 Lundbeck Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis CGRP Antagonists Major Product Offerings
7.7.4 Novartis CGRP Antagonists Sales and Revenue in Global (2018-2023)
7.7.5 Novartis Key News & Latest Developments
8 Global CGRP Antagonists Production Capacity, Analysis
8.1 Global CGRP Antagonists Production Capacity, 2018-2029
8.2 CGRP Antagonists Production Capacity of Key Manufacturers in Global Market
8.3 Global CGRP Antagonists Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CGRP Antagonists Supply Chain Analysis
10.1 CGRP Antagonists Industry Value Chain
10.2 CGRP Antagonists Upstream Market
10.3 CGRP Antagonists Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 CGRP Antagonists Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of CGRP Antagonists in Global Market
Table 2. Top CGRP Antagonists Players in Global Market, Ranking by Revenue (2022)
Table 3. Global CGRP Antagonists Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global CGRP Antagonists Revenue Share by Companies, 2018-2023
Table 5. Global CGRP Antagonists Sales by Companies, (K Units), 2018-2023
Table 6. Global CGRP Antagonists Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers CGRP Antagonists Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers CGRP Antagonists Product Type
Table 9. List of Global Tier 1 CGRP Antagonists Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CGRP Antagonists Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global CGRP Antagonists Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global CGRP Antagonists Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global CGRP Antagonists Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global CGRP Antagonists Sales (K Units), 2018-2023
Table 15. By Type - Global CGRP Antagonists Sales (K Units), 2024-2029
Table 16. By Application – Global CGRP Antagonists Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global CGRP Antagonists Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global CGRP Antagonists Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global CGRP Antagonists Sales (K Units), 2018-2023
Table 20. By Application - Global CGRP Antagonists Sales (K Units), 2024-2029
Table 21. By Region – Global CGRP Antagonists Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global CGRP Antagonists Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global CGRP Antagonists Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global CGRP Antagonists Sales (K Units), 2018-2023
Table 25. By Region - Global CGRP Antagonists Sales (K Units), 2024-2029
Table 26. By Country - North America CGRP Antagonists Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America CGRP Antagonists Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America CGRP Antagonists Sales, (K Units), 2018-2023
Table 29. By Country - North America CGRP Antagonists Sales, (K Units), 2024-2029
Table 30. By Country - Europe CGRP Antagonists Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe CGRP Antagonists Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe CGRP Antagonists Sales, (K Units), 2018-2023
Table 33. By Country - Europe CGRP Antagonists Sales, (K Units), 2024-2029
Table 34. By Region - Asia CGRP Antagonists Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia CGRP Antagonists Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia CGRP Antagonists Sales, (K Units), 2018-2023
Table 37. By Region - Asia CGRP Antagonists Sales, (K Units), 2024-2029
Table 38. By Country - South America CGRP Antagonists Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America CGRP Antagonists Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America CGRP Antagonists Sales, (K Units), 2018-2023
Table 41. By Country - South America CGRP Antagonists Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa CGRP Antagonists Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa CGRP Antagonists Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa CGRP Antagonists Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa CGRP Antagonists Sales, (K Units), 2024-2029
Table 46. PFIZER INC(Biohaven) Company Summary
Table 47. PFIZER INC(Biohaven) CGRP Antagonists Product Offerings
Table 48. PFIZER INC(Biohaven) CGRP Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. PFIZER INC(Biohaven) Key News & Latest Developments
Table 50. ABBVIE INC Company Summary
Table 51. ABBVIE INC CGRP Antagonists Product Offerings
Table 52. ABBVIE INC CGRP Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. ABBVIE INC Key News & Latest Developments
Table 54. Amgen Company Summary
Table 55. Amgen CGRP Antagonists Product Offerings
Table 56. Amgen CGRP Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Amgen Key News & Latest Developments
Table 58. Teva Company Summary
Table 59. Teva CGRP Antagonists Product Offerings
Table 60. Teva CGRP Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Teva Key News & Latest Developments
Table 62. Eli Lilly and Company Company Summary
Table 63. Eli Lilly and Company CGRP Antagonists Product Offerings
Table 64. Eli Lilly and Company CGRP Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Eli Lilly and Company Key News & Latest Developments
Table 66. Lundbeck Company Summary
Table 67. Lundbeck CGRP Antagonists Product Offerings
Table 68. Lundbeck CGRP Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Lundbeck Key News & Latest Developments
Table 70. Novartis Company Summary
Table 71. Novartis CGRP Antagonists Product Offerings
Table 72. Novartis CGRP Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Novartis Key News & Latest Developments
Table 74. CGRP Antagonists Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global CGRP Antagonists Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global CGRP Antagonists Production by Region, 2018-2023 (K Units)
Table 77. Global CGRP Antagonists Production by Region, 2024-2029 (K Units)
Table 78. CGRP Antagonists Market Opportunities & Trends in Global Market
Table 79. CGRP Antagonists Market Drivers in Global Market
Table 80. CGRP Antagonists Market Restraints in Global Market
Table 81. CGRP Antagonists Raw Materials
Table 82. CGRP Antagonists Raw Materials Suppliers in Global Market
Table 83. Typical CGRP Antagonists Downstream
Table 84. CGRP Antagonists Downstream Clients in Global Market
Table 85. CGRP Antagonists Distributors and Sales Agents in Global Market
List of Figures
Figure 1. CGRP Antagonists Segment by Type in 2022
Figure 2. CGRP Antagonists Segment by Application in 2022
Figure 3. Global CGRP Antagonists Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CGRP Antagonists Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global CGRP Antagonists Revenue, 2018-2029 (US$, Mn)
Figure 7. CGRP Antagonists Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by CGRP Antagonists Revenue in 2022
Figure 9. By Type - Global CGRP Antagonists Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global CGRP Antagonists Revenue Market Share, 2018-2029
Figure 11. By Type - Global CGRP Antagonists Sales Market Share, 2018-2029
Figure 12. By Type - Global CGRP Antagonists Price (US$/Unit), 2018-2029
Figure 13. By Application - Global CGRP Antagonists Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global CGRP Antagonists Revenue Market Share, 2018-2029
Figure 15. By Application - Global CGRP Antagonists Sales Market Share, 2018-2029
Figure 16. By Application - Global CGRP Antagonists Price (US$/Unit), 2018-2029
Figure 17. By Region - Global CGRP Antagonists Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global CGRP Antagonists Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global CGRP Antagonists Revenue Market Share, 2018-2029
Figure 20. By Region - Global CGRP Antagonists Sales Market Share, 2018-2029
Figure 21. By Country - North America CGRP Antagonists Revenue Market Share, 2018-2029
Figure 22. By Country - North America CGRP Antagonists Sales Market Share, 2018-2029
Figure 23. US CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 24. Canada CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe CGRP Antagonists Revenue Market Share, 2018-2029
Figure 27. By Country - Europe CGRP Antagonists Sales Market Share, 2018-2029
Figure 28. Germany CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 29. France CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 31. Italy CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 32. Russia CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia CGRP Antagonists Revenue Market Share, 2018-2029
Figure 36. By Region - Asia CGRP Antagonists Sales Market Share, 2018-2029
Figure 37. China CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 38. Japan CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 41. India CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America CGRP Antagonists Revenue Market Share, 2018-2029
Figure 43. By Country - South America CGRP Antagonists Sales Market Share, 2018-2029
Figure 44. Brazil CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa CGRP Antagonists Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa CGRP Antagonists Sales Market Share, 2018-2029
Figure 48. Turkey CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 49. Israel CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 51. UAE CGRP Antagonists Revenue, (US$, Mn), 2018-2029
Figure 52. Global CGRP Antagonists Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production CGRP Antagonists by Region, 2022 VS 2029
Figure 54. CGRP Antagonists Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 咳喘息（CVA）治療薬のグローバル市場展望 2023年-2029年：気管支拡張剤、ロイコトリエン拮抗剤、肥満細胞安定剤、コルチコステロイド、モノクローナル抗体
  • タンパク質阻害剤のグローバル市場展望 2023年-2029年：プロテインキナーゼ阻害剤、モノクローナル抗体、その他
  • 抗VEGT薬のグローバル市場展望 2023年-2029年：チロシンキナーゼ阻害剤、モノクローナル抗体、その他
  • VDAC1抗体のグローバル市場展望 2023年-2029年：モノクローナル抗体、ポリクローナル抗体
  • SOX2抗体のグローバル市場展望 2023年-2029年：モノクローナル抗体、ポリクローナル抗体
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14275 )"CGRPアンタゴニストのグローバル市場展望 2023年-2029年：モノクローナル抗体、CGRP受容体阻害剤" (英文：CGRP Antagonists Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。